Prohibiting, except under certain circumstances, insurers, nonprofit health service plans, and health maintenance organizations that provide coverage for diagnostic and supplemental breast examinations from imposing a copayment, coinsurance, or deductible requirement for the examination; and requiring the Maryland Health Care Commission to study and report to the Governor and certain committees of the General Assembly by October 1, 2023, on the financial impact of eliminating cost-sharing for diagnostic image-guided biopsies for breast cancer.